All In Biotech

Investigational drug · Phase 3

IRP101

Also called: meta-fluorobenzylguanidine, 18F-MFBG, 18F-mFBG for administration, 18F-metaFluorobenzylguanidine

Not approved by FDA. In 4 industry-sponsored Phase 2 or 3 trials that are active or finished in the last two years, most often for Cardiovascular Diseases, Heart Failure, Ischemic Cardiomyopathy.

Phase 3

Last checked: Nov 19, 2026Latest source record: Nov 17, 2026 (newest trial update)Source: ClinicalTrials.govMethods & limitations

Highest phase

Phase 3

Industry-sponsored trials

Phase 2 and 3 trials

4

3 still active

All registered trials

3

Any phase or sponsor naming "IRP101"

First trial start

2021

Nov 5, 2021

Sponsors

Lead sponsors of its Phase 2 and 3 trials.

All registered trials by phase

Every ClinicalTrials.gov drug study naming "IRP101", any sponsor or status.

Conditions studied

As listed on its trial records.

  • Cardiovascular Diseases
  • Heart Failure
  • Ischemic Cardiomyopathy
  • ICD Patients
  • Parkinson Disease (PD)
  • Lewy Body Dementia (LBD)
  • Neuroblastoma

Approved drugs for the same conditions: Heart failure · Parkinson's disease · Cardiovascular and metabolic · Neurology

Largest trials

Live from ClinicalTrials.gov: studies naming "IRP101" as an intervention, largest first.

All trials

Newest research

PubMed records naming it or its code names, newest first.

All 44 on PubMed

Also in development for Cardiovascular Diseases

  • EloralintideLY3841136Phase 313 trials

    Eli Lilly · Obesity, Overweight, Diabetes Mellitus, Type 2

  • VicadrostatBI 690517Phase 35 trials

    Boehringer Ingelheim · Heart Failure, Diabetes Mellitus, Type 2, Hypertension

  • LepodisiranLY3819469Phase 32 trials

    Eli Lilly · Atherosclerosis, Cardiovascular Diseases, Lipoprotein(a)

  • MosliciguatPhase 32 trials

    Pulmovant, Inc. · Pulmonary Hypertension, Interstitial Lung Disease, Vascular Diseases

  • RalinepagAPD811Phase 32 trials

    United Therapeutics · PAH, Pulmonary Hypertension, Pulmonary Arterial Hypertension

  • StromaForteHuman Allogeneic Bone-Marrow-Derived Mesenchymal Stromal Cell Product, MSCsPhase 25 trials

    Cellcolabs Clinical LTD. · Cardiovascular Diseases, Frailty, Musculoskeletal Injury

  • IMR-687Tovinontrine, CRD-750Phase 23 trials

    Cardurion Pharmaceuticals, Inc. · Heart Failure, Cardiovascular Diseases, Heart Diseases

  • SPC 2002Phase 21 trial

    Shin Poong Pharmaceutical Co. Ltd. · Hypertension, Essential, Cardiovascular Diseases, Cardiology

Names are merged from how sponsors list this drug on ClinicalTrials.gov, so an alias can occasionally belong to a related compound. Development status changes faster than registry records do.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.